The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $30.55

Today's change0.00 0.00%
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $30.55

Today's change0.00 0.00%
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.

Wright Medical Group NV closed at (U.S.)$30.55.

Over the last five days, shares have gained 4.59% and are currently 2.43% off of the 52-week high. Shares have outperformed the S&P 500 by 74.50% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $30.55
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.01 / (U.S.) $200.00K
  • YTD % change+32.94%
  • Volume0
  • Average volume (10-day)1,174,218
  • Average volume (1-month)1,165,156
  • Average volume (3-month)850,557
  • 52-week range(U.S.) $15.52 to (U.S.) $31.31
  • Beta0.99
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.60
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-23.89%

Wright Medical Group NV has a net profit margin of -23.89%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 25, 201612/25/2016Sep 25, 201609/25/2016Jun 26, 201606/26/2016Mar 27, 201603/27/2016
Revenue193157171169
Total other revenue--------
Total revenue193157171169
Gross profit142111122123
Total cost of revenue51464947
Total operating expense212196205200
Selling / general / administrative140130136135
Research & development14121212
Depreciation / amortization7776
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-19-39-34-31
Interest income (expense), net non-operating-17-17-13-12
Gain (loss) on sale of assets--------
Other--------
Income before tax-36-55-45-41
Income after tax-30-53-42-40
Income tax, total-6-2-3-1
Net income-45-110-229-48
Total adjustments to net income--------
Net income before extra. items-30-53-42-40
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-30-53-42-40
Inc. avail. to common incl. extra. items-45-110-229-48
Diluted net income-45-110-229-48
Dilution adjustment--0----
Diluted weighted average shares103103103103
Diluted EPS excluding extraordinary itemsvalue per share-0.29-0.51-0.41-0.39
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.29-0.51-0.41-0.39